2005
DOI: 10.1007/s10156-005-0381-3
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of pazufloxacin mesilate in Legionnaires’ disease: a case report and in vitro study of the isolate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2005
2005
2010
2010

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 20 publications
0
3
0
Order By: Relevance
“…pneumophila is very susceptible to several antibiotics, such as the fluoroquinolones, ketolides and macrolides [14]. Pazufloxacin, a fluoroquinolone antibiotic available in Japan, is also effective against Legionella [19,23]. In this study, pazufloxacin showed slight decrease of the number of viable bacteria, however, the combination therapy showed more effective for decreasing of bacteria with a significant difference in spite of the short duration of treatment.…”
Section: Discussionmentioning
confidence: 59%
“…pneumophila is very susceptible to several antibiotics, such as the fluoroquinolones, ketolides and macrolides [14]. Pazufloxacin, a fluoroquinolone antibiotic available in Japan, is also effective against Legionella [19,23]. In this study, pazufloxacin showed slight decrease of the number of viable bacteria, however, the combination therapy showed more effective for decreasing of bacteria with a significant difference in spite of the short duration of treatment.…”
Section: Discussionmentioning
confidence: 59%
“…[17][18][19][20] This case confi rmed the effi cacy of intravenous fl uoroquinolones in pneumonia due to L. pneumophila SG 2 in combination with a macrolide. The combination therapy of CPFX and a macrolide was reported to be effective during an in vitro study, 21 which warranted further study.…”
Section: Discussionmentioning
confidence: 87%
“…We successfully treated the patient with severe Legionella pneumonia with ARDS using a combination of fluoroquin- ' s c l i n i c a l c o u r s (9) (12). Recently, a randomized, controlled study found that chronic, low-dose corticosteroid therapy was effective in patients with severe communityacquired pneumonia (13) (17), and bleomycin-induced fibrosis (18).…”
Section: Discussionmentioning
confidence: 99%